{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05280548",
            "orgStudyIdInfo": {
                "id": "EFC16158"
            },
            "secondaryIdInfos": [
                {
                    "id": "U1111-1266-5068",
                    "type": "REGISTRY",
                    "domain": "ICTRP"
                },
                {
                    "id": "2023-509715-91",
                    "type": "REGISTRY",
                    "domain": "CTIS"
                },
                {
                    "id": "2021-002320-20",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Sanofi",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease",
            "officialTitle": "A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular Hypertrophy",
            "acronym": "CARAT",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-the-effect-of-venglustat-tablets-on-left-ventricular-mass-index-in-male-and-female-adult-participants-with-fabry-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-07-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-04",
            "studyFirstSubmitQcDate": "2022-03-04",
            "studyFirstPostDateStruct": {
                "date": "2022-03-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sanofi",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is an 18-month, multicenter, randomized, active-control, parallel-group Phase 3 study, in which participants will be randomized to venglustat versus standard of care therapy (agalsidase alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.\n\n* Study visits will take place approximately every 3 to 6 months\n* Participants who complete the randomized period may continue to the long-term extension (LTE) to receive venglustat for up to additional 34 months with the total study duration up to 4.4 years maximum.",
            "detailedDescription": "Randomized period: the total duration will be up to approximately of 20 months (1 month screening 18 months of treatment and a possible follow-up period of 1 month if no participation in the long-term extension period)\n\nLong-term extension period: the total duration will be from minimum 19 months (18 months of treatment and 1 month of follow-up period) to maximum 35 months (34 months of treatment and 1 month of follow-up period). The maximum total study duration is approximately 4.4 years"
        },
        "conditionsModule": {
            "conditions": [
                "Fabry Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Venglustat",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive venglustat once daily, orally",
                    "interventionNames": [
                        "Drug: Venglustat (GZ402671)"
                    ]
                },
                {
                    "label": "Standard of Care Therapy",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive a locally approved Fabry therapy at the standard dose and schedule (in accordance with the locally approved prescribing information)",
                    "interventionNames": [
                        "Drug: Agalsidase alfa",
                        "Drug: Agalsidase beta (GZ419828)",
                        "Drug: Migalastat"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Venglustat (GZ402671)",
                    "description": "Tablet; Oral",
                    "armGroupLabels": [
                        "Venglustat"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Agalsidase alfa",
                    "description": "Concentrate for solution for infusion; IV infusion",
                    "armGroupLabels": [
                        "Standard of Care Therapy"
                    ],
                    "otherNames": [
                        "Replagal\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Agalsidase beta (GZ419828)",
                    "description": "Powder for concentrate for solution for infusion; IV infusion",
                    "armGroupLabels": [
                        "Standard of Care Therapy"
                    ],
                    "otherNames": [
                        "Fabrazyme\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Migalastat",
                    "description": "Hard capsules; Oral",
                    "armGroupLabels": [
                        "Standard of Care Therapy"
                    ],
                    "otherNames": [
                        "Galafold\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Slope of left ventricular mass index as measured by cardiac magnetic resonance imaging (MRI) (central reading)",
                    "timeFrame": "from baseline to 18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Slope of estimated glomerular filtration rate (eGFR) as assessed by the chronic kidney disease epidemiology collaboration (CKD-EPI) creatinine equation",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Change in T1 relaxation time, measured by cardiac MRI (central reading)",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Change in global longitudinal strain, measured by echocardiography (central reading)",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Percent Change in tiredness component of FD-PRO",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Percent Change in swelling in lower extremities component of FD-PRO",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Number of participants with adverse event (AE) and serious adverse event (SAE)",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Change in Beck Depression Inventory-II (BDI-II) score",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Change in the lens clarity by ophthalmological examination",
                    "timeFrame": "from baseline to 18 months"
                },
                {
                    "measure": "Plasma venglustat concentrations at prespecified visits over the study duration",
                    "timeFrame": "from baseline to 18 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female participants aged 18 to 65 with previously confirmed diagnosis of Fabry disease and a history of clinical symptoms of Fabry disease.\n* Participants may be receiving treatment with agalsidase alfa, agalsidase beta, or migalastat, or may be untreated.\n* Left ventricular hypertrophy.\n* Contraception for male or female participants: not pregnant or breastfeeding; no sperm donating for male participant.\n* A signed informed consent must be provided prior to any study-related procedures.\n\nExclusion Criteria:\n\n* History of transient ischemic attack, stroke, myocardial infarction, heart failure, major cardiovascular surgery or kidney transplantation.\n* History of seizures currently requiring treatment.\n* Underlying medical condition that may cause or contribute to left ventricular hypertrophy.\n* Asymmetric hypertrophy by cardiac MRI at screening if considered by central reader to be not related to Fabry disease.\n* Advanced cardiac fibrosis, defined as significant late gadolinium enhancement affecting 3 or more segments involving \\>50% of myocardial thickness on screening cardiac MRI.\n* History of clinically significant cardiac arrhythmia. Atrial fibrillation that is well controlled on a stable medical regimen for at least 12 months is not an exclusion if the CHA2DS2-VASc score is 0 for males or 1 for females.\n* Estimated glomerular filtration rate \\<45 mL/min/1.73m2.\n* Presence of severe depression as measured by Beck's Depression Inventory (BDI)-II \\>28 and/or a history of an untreated, unstable major affective disorder within 1 year of the screening visit.\n* Patients with hepatitis C, HIV, or hepatitis B infection.\n* Positive SARS-CoV-2 virus test within 2 weeks of enrollment, or COVID-19 requiring hospitalization within 6 months of enrollment.\n* History of drug and/or alcohol abuse.\n* Moderate to severe hepatic impairment.\n* History of or active hepatobiliary disease.\n* Liver enzymes (alanine aminotransferase/aspartate aminotransferase) or total bilirubin \\>2 times the upper limit of normal.\n* Strong or moderate inducers or inhibitors of cytochrome P450 CYP3A4 within 14 days or 5 half-lives, whichever is longer, prior to randomization.\n* Known contraindication to undergoing MRI or known hypersensitivity to gadolinium-based contrast agents.\n\nThe above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trial Transparency email recommended (Toll free for US & Canada)",
                    "role": "CONTACT",
                    "phone": "800-633-1610",
                    "phoneExt": "option 6",
                    "email": "Contact-US@sanofi.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Sciences & Operations Clinical Sciences and Operations",
                    "affiliation": "Sanofi",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham (UAB) - The Kirklin Clin Site Number : 8400010",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233-2110",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "UCLA Medical Center Site Number : 8400008",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Emory Clinic Site Number : 8400009",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Ann and Robert H Lurie Children's Hospital of Chicago Site Number : 8400005",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Maryam Banikazemi, MD Site Number : 8400001",
                    "status": "RECRUITING",
                    "city": "Hawthorne",
                    "state": "New York",
                    "zip": "10532",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.10732,
                        "lon": -73.79597
                    }
                },
                {
                    "facility": "Renal Disease Research Institute Site Number : 8400012",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "University of Utah Medical Center Site Number : 8400006",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84132",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 8400004",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Investigational Site Number : 0400001",
                    "status": "RECRUITING",
                    "city": "Graz",
                    "zip": "8036",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.06667,
                        "lon": 15.45
                    }
                },
                {
                    "facility": "Investigational Site Number : 1240006",
                    "status": "COMPLETED",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 2B7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Investigational Site Number : 1240002",
                    "status": "RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V5Z 1M9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "Investigational Site Number : 1240005",
                    "status": "COMPLETED",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5T 3L9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560002",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100034",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560005",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100044",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560001",
                    "status": "RECRUITING",
                    "city": "Chengdu",
                    "zip": "610041",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.66667,
                        "lon": 104.06667
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560007",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "zip": "510080",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Investigational Site Number : 1560003",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200025",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Investigational Site Number : 2030001",
                    "status": "RECRUITING",
                    "city": "Praha 2",
                    "zip": "12808",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 50.08804,
                        "lon": 14.42076
                    }
                },
                {
                    "facility": "Investigational Site Number : 2080001",
                    "status": "RECRUITING",
                    "city": "Copenhagen",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Investigational Site Number : 2500001",
                    "status": "RECRUITING",
                    "city": "Garches",
                    "zip": "92380",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.84226,
                        "lon": 2.18232
                    }
                },
                {
                    "facility": "Investigational Site Number : 2760003",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "10117",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Investigational Site Number : 2760004",
                    "status": "RECRUITING",
                    "city": "Hochheim am Main",
                    "zip": "65239",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.01436,
                        "lon": 8.35218
                    }
                },
                {
                    "facility": "Investigational Site Number : 2760001",
                    "status": "RECRUITING",
                    "city": "W\u00fcrzburg",
                    "zip": "97080",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.79391,
                        "lon": 9.95121
                    }
                },
                {
                    "facility": "Investigational Site Number : 3000002",
                    "status": "RECRUITING",
                    "city": "Athens",
                    "zip": "11527",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Investigational Site Number : 3000003",
                    "status": "RECRUITING",
                    "city": "Athens",
                    "zip": "12462",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "Investigational Site Number : 3000001",
                    "status": "RECRUITING",
                    "city": "Heraklion",
                    "zip": "71500",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 35.32787,
                        "lon": 25.14341
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800001",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "state": "Lombardia",
                    "zip": "20122",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800004",
                    "status": "RECRUITING",
                    "city": "Bologna",
                    "zip": "40138",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800002",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Investigational Site Number : 3800003",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920004",
                    "status": "RECRUITING",
                    "city": "Fukuoka-shi",
                    "state": "Fukuoka",
                    "zip": "814-0180",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.6,
                        "lon": 130.41667
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920003",
                    "status": "COMPLETED",
                    "city": "Kagoshima-shi",
                    "state": "Kagoshima",
                    "zip": "890-8520",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 31.56667,
                        "lon": 130.55
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920005",
                    "status": "RECRUITING",
                    "city": "Kawasaki-shi",
                    "state": "Kanagawa",
                    "zip": "215-0026",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.52056,
                        "lon": 139.71722
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920002",
                    "status": "RECRUITING",
                    "city": "Sendai-shi",
                    "state": "Miyagi",
                    "zip": "980-8574",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Investigational Site Number : 3920001",
                    "status": "RECRUITING",
                    "city": "Minato-ku",
                    "state": "Tokyo",
                    "zip": "105-8471",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.2152,
                        "lon": 135.1501
                    }
                },
                {
                    "facility": "Investigational Site Number : 4100002",
                    "status": "RECRUITING",
                    "city": "Yangsan-si",
                    "state": "Gyeongsangnam-do",
                    "country": "Korea, Republic of"
                },
                {
                    "facility": "Investigational Site Number : 4100001",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul-teukbyeolsi",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Investigational Site Number : 5280001",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "zip": "1105 AZ",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Investigational Site Number : 5780001",
                    "status": "RECRUITING",
                    "city": "Bergen",
                    "zip": "5021",
                    "country": "Norway",
                    "geoPoint": {
                        "lat": 60.39299,
                        "lon": 5.32415
                    }
                },
                {
                    "facility": "Investigational Site Number : 6160001",
                    "status": "RECRUITING",
                    "city": "Krakow",
                    "zip": "31-202",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.06143,
                        "lon": 19.93658
                    }
                },
                {
                    "facility": "Investigational Site Number : 7240002",
                    "status": "RECRUITING",
                    "city": "Madrid / Madrid",
                    "state": "Madrid, Comunidad De",
                    "zip": "28007",
                    "country": "Spain"
                },
                {
                    "facility": "Investigational Site Number : 7240003",
                    "status": "RECRUITING",
                    "city": "Alicante",
                    "zip": "03010",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 38.34517,
                        "lon": -0.48149
                    }
                },
                {
                    "facility": "Investigational Site Number : 7240001",
                    "status": "RECRUITING",
                    "city": "Vigo",
                    "zip": "36312",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.23282,
                        "lon": -8.72264
                    }
                },
                {
                    "facility": "Investigational Site Number : 1580003",
                    "status": "RECRUITING",
                    "city": "Taichung",
                    "zip": "407",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Investigational Site Number : 1580001",
                    "status": "RECRUITING",
                    "city": "Taipei 104",
                    "zip": "104",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Investigational Site Number : 7920001",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06500",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Investigational Site Number : 7920002",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34303",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Investigational Site Number : 7920003",
                    "status": "RECRUITING",
                    "city": "Kocaeli",
                    "zip": "41380",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 39.62497,
                        "lon": 27.51145
                    }
                },
                {
                    "facility": "Investigational Site Number : 8260001",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "London, City Of",
                    "zip": "NW3 2QG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000795",
                    "term": "Fabry Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013106",
                    "term": "Sphingolipidoses"
                },
                {
                    "id": "D000020140",
                    "term": "Lysosomal Storage Diseases, Nervous System"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000059345",
                    "term": "Cerebral Small Vessel Diseases"
                },
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008064",
                    "term": "Lipidoses"
                },
                {
                    "id": "D000008052",
                    "term": "Lipid Metabolism, Inborn Errors"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10035",
                    "name": "Hypertrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M4124",
                    "name": "Fabry Disease",
                    "asFound": "Fabry Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19658",
                    "name": "Hypertrophy, Left Ventricular",
                    "relevance": "LOW"
                },
                {
                    "id": "M15904",
                    "name": "Sphingolipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M29437",
                    "name": "Cerebral Small Vessel Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11064",
                    "name": "Lipidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M11054",
                    "name": "Lipid Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2169",
                    "name": "Fabry Disease",
                    "asFound": "Fabry Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5335",
                    "name": "Sphingolipidosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000608118",
                    "term": "Venglustat"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M349697",
                    "name": "Venglustat",
                    "asFound": "FLT3-ITD",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}